Company Number: 14157076

Analysis Date: 2025-07-29 20:51 UTC

1. Credit Opinion: DECLINE
   The Cream Lab Limited currently exhibits weak financial health with very limited net assets (£847) and significant net current liabilities (£59,243) as of the latest accounts. The company’s current liabilities far exceed its current assets, indicating liquidity stress and poor working capital management. As a recently incorporated micro-entity (since June 2022) with no employees and minimal operational scale, it demonstrates limited ability to service debt obligations or absorb financial shocks. The negative working capital and negligible equity base raise concerns about ongoing solvency and business resilience. The absence of audit and limited financial disclosures further constrain risk assessment. Given these factors, the company is not currently creditworthy for lending without substantial improvement or additional security.

2. Financial Strength:
   The balance sheet reveals very low fixed assets (£62,430) and minimal current assets (£10,674) offset by high current liabilities (£254,917). Despite a small increase in net assets from £100 to £847 over one year, the company remains heavily reliant on creditor funding with net current liabilities exceeding £59k. Shareholders’ funds are minimal and provide little cushion against operational or financial risks. The micro-entity status restricts detailed financial analysis but the available data points to a fragile capital structure lacking robust equity or cash reserves.

3. Cash Flow Assessment:
   The company’s negative net current assets position suggests liquidity challenges and potential difficulties meeting short-term obligations. The substantial creditors balance relative to cash and debtor balances implies heavy reliance on supplier credit or short-term funding. The lack of employees and presumably low operational scale may limit cash outflows, but also restrict revenue generation capacity. Without cash flow statements or profit & loss data, the working capital cycle and operational cash generation remain unclear, but current indicators signal tight liquidity and elevated risk of cash shortfall.

4. Monitoring Points:

• Quarterly updates on cash flow and creditor turnover to detect liquidity trends.
• Changes in current liabilities and creditor terms to assess funding pressure.
• Any new capital injections or share issuances improving equity base.
• Business revenue growth and profitability metrics when available.
• Director conduct and company filings compliance to monitor governance.